We are live on ! Find out more
Citigroup

Citigroup Portfolio holdings

AUM $303B
1-Year Est. Return 53.02%
 

Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.

This Fund
S&P 500
This Quarter Est. Return
+15.15%
1 Year Est. Return
+53.02%
3 Year Est. Return
+141.18%
5 Year Est. Return
+166.47%
10 Year Est. Return
+624.92%
AUM
$204B
AUM Growth
+$7.93B
Cap. Flow
-$14.6B
Cap. Flow %
-7.18%
Top 10 Hldgs %
19.82%
Holding
6,003
New
468
Increased
1,653
Reduced
2,974
Closed
377

Sector Composition

Rank Sector Weight
1 Technology 20.55%
2 Financials 7.82%
3 Consumer Discretionary 7.65%
4 Communication Services 5.12%
5 Healthcare 5.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CINT icon
5051
CI&T Inc
CINT
$467M
$7.28K ﹤0.01%
+1,219
New +$7.02K
LYRA
5052
DELISTED
LYRA THERAPEUTICS INC
LYRA
$7.12K ﹤0.01%
795
+91
+13% +$755
VTGN icon
5053
VistaGen Therapeutics
VTGN
$11.7M
$7.08K ﹤0.01%
3,539
+3,536
+117,867% +$8.03K
CTNM
5054
Contineum Therapeutics
CTNM
$545M
$7.04K ﹤0.01%
1,774
-5,613
-76% -$24.4K
CPSH icon
5055
CPS Technologies
CPSH
$83.8M
$6.92K ﹤0.01%
+2,500
New +$5.33K
SILO icon
5056
Silo Pharma
SILO
$4.73M
$6.85K ﹤0.01%
724
+622
+610% +$7.13K
STTK icon
5057
Shattuck Labs
STTK
$682M
$6.8K ﹤0.01%
8,588
-19,955
-70% -$19.4K
AVDV icon
5058
Avantis International Small Cap Value ETF
AVDV
$19.7B
$6.74K ﹤0.01%
85
+83
+4,150% +$6.14K
GURE
5059
Gulf Resources
GURE
$4.71M
$6.74K ﹤0.01%
+1,003
New +$6.74K
ARL icon
5060
American Realty Investors
ARL
$243M
$6.71K ﹤0.01%
475
-581
-55% -$7.59K
CORZZ icon
5061
CALL
Core Scientific Inc Tranche 2 Warrants
CORZZ
$1.63B
$6.64K ﹤0.01%
387
CMTL icon
5062
Comtech Telecommunications
CMTL
$51.5M
$6.62K ﹤0.01%
2,703
+2,701
+135,050% +$4.86K
SDOG icon
5063
ALPS Sector Dividend Dogs ETF
SDOG
$1.43B
$6.61K ﹤0.01%
+115
New +$6.41K
IDHQ icon
5064
Invesco S&P International Developed Quality ETF
IDHQ
$987M
$6.6K ﹤0.01%
200
UHG
5065
DELISTED
United Homes Group
UHG
$6.41K ﹤0.01%
2,209
-4,276
-66% -$11.1K
BCYC
5066
Bicycle Therapeutics
BCYC
$288M
$6.34K ﹤0.01%
913
+224
+33% +$1.78K
HAP icon
5067
VanEck Natural Resources ETF
HAP
$309M
$6.29K ﹤0.01%
121
-39
-24% -$1.93K
DSX icon
5068
Diana Shipping
DSX
$296M
$6.26K ﹤0.01%
+4,286
New +$6.44K
AMRN
5069
Amarin Corp
AMRN
$298M
$6.21K ﹤0.01%
383
+92
+32% +$1.03K
NTIC icon
5070
Northern Technologies International Corp
NTIC
$77M
$6.16K ﹤0.01%
831
-4,884
-85% -$37.3K
HBIO icon
5071
Harvard Bioscience
HBIO
$28.8M
$6.14K ﹤0.01%
1,383
-1,557
-53% -$6.51K
CRVO icon
5072
CervoMed
CRVO
$26.5M
$6.04K ﹤0.01%
961
-2,884
-75% -$24.6K
FYT icon
5073
First Trust Small Cap Value AlphaDEX Fund
FYT
$199M
$5.87K ﹤0.01%
116
MGRM
5074
DELISTED
Monogram Orthopaedics
MGRM
$5.78K ﹤0.01%
2,000
IXHL icon
5075
Incannex Healthcare
IXHL
$38.6M
$5.71K ﹤0.01%
+882
New +$8.72K

Similar funds

Citigroup's Q2 2025 Portfolio in Review

As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.

  • Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
  • Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
  • Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
  • Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
  • Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
  • Citigroup opened 468 new positions and closed 377 in Q2 2025.
  • Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.

Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.